A

Apimeds Pharmaceuticals US, Inc.

APUS

Market valuation vs the Bitcoin it holds

0.31×
Discount
a 69% discount to Bitcoin NAV

Apimeds Pharmaceuticals US, Inc. trades at 0.31× its Bitcoin NAV — you pay 31¢ for every $1 of Bitcoin it holds, a 63.9M USD pile.

Live · last updated

BTC held
1000 BTC
Bitcoin treasury
Bitcoin NAV
63.9M USD
at today's BTC price
Market cap
19.8M USD
Fully diluted
Share price
1.31 USD
USD
Last BTC buy
1000 BTC
Dec 10, 2025

mNAV over time

Full history · diluted

Today's 0.31× sits in a 52-week range of 0.26× to 0.33×.

mNAV · 52-week range
0.26×–0.33×
0.26×now 0.31×0.33×

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. (APUS) owns 1000 BTC. At today's price that Bitcoin is worth 63.9M USD. The market caps the whole company at 19.8M USD 0.31× its Bitcoin. Put plainly: you pay 31¢ for every $1 of Bitcoin it holds, a 69% discount to simply owning the coins. It bought in at an average of 92.1K USD per coin.

Apimeds Pharmaceuticals US, Inc. (APUS) mNAV — frequently asked

What is Apimeds Pharmaceuticals US, Inc. (APUS)'s mNAV?
Apimeds Pharmaceuticals US, Inc.'s mNAV is currently 0.31×. mNAV divides APUS's market capitalisation by the value of the Bitcoin it holds, so 0.31× means the market values the company at 0.31× the worth of its Bitcoin treasury (63.9M USD).
Is Apimeds Pharmaceuticals US, Inc. (APUS) overvalued versus its Bitcoin?
At 0.31×, Apimeds Pharmaceuticals US, Inc. (APUS) trades at a 69% discount to the Bitcoin it holds. Whether that is rich or cheap is best read against its own history: over the past year its mNAV has ranged 0.26×–0.33×.
How much Bitcoin does Apimeds Pharmaceuticals US, Inc. (APUS) hold?
Apimeds Pharmaceuticals US, Inc. holds 1000 BTC, worth 63.9M USD at current prices. Its most recent purchase was 1000 BTC on Dec 10, 2025.

Related datapoints